Last week, readers were most interested in a story about Agilent changing two of its three business organizations to accelerate growth.

Out of the 30 companies tracked by 360Dx, 13 saw their share prices increase, while 17 saw their stock prices decline.

The awards will support the development of US Food and Drug Administration-cleared tests for Marburg virus and Burkholderia pseudomallei infection.

Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.

NEW YORK – Natera announced on Wednesday that its Prospera Lung test has received coverage from the US Centers for Medicare and Medicaid Services for single lung transplant patients in the ...

The HemoScreen instrument is a point-of-care five-part differential complete blood count analyzer that is used for rapid testing from a drop of blood.

The company, based outside of Grenoble in the French Alps, together with its partners has received €5 million to pursue the project.

The next-generation version of the Cologuard test received FDA approval last month and is expected to launch next year.

The company's CircleDNA and ACT Genomics businesses are on track to achieve business-unit breakeven in the second half of 2024, it said.

The company said that gains in its Agilent CrossLab Group offset losses across its other two divisions as the company undertakes restructuring to grow as the market improves.